Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Neogen Corporation (NEOG) stocks in Canada

Learn how to easily invest in Neogen Corporation stocks.

Neogen Corporation is a diagnostics & research business based in the US. Neogen Corporation stocks (NEOG.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $46.19 – a decrease of 9.99% over the previous week. Neogen Corporation employs 1,841 staff and has a trailing 12-month revenue of around $503 million.

How to buy shares in Neogen Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NEOG – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Neogen Corporation stock price (NASDAQ:NEOG)

Use our graph to track the performance of NEOG stocks over time.

Neogen Corporation shares at a glance

Information last updated 2022-01-17.
Latest market close$35.03
52-week range$38.24 - $48.85
50-day moving average $42.88
200-day moving average $44.00
Wall St. target price$55.00
PE ratio 73.434
Dividend yield N/A (0%)
Earnings per share (TTM) $0.53

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Neogen Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Neogen Corporation price performance over time

Historical closes compared with the close of $35.03 from 2022-01-21

1 week (2022-01-14) -9.99%
1 month (2021-12-23) -21.12%
3 months (2021-10-22) -14.75%
6 months (2021-07-23) -19.25%
1 year (2021-01-22) -59.35%
2 years (2020-01-24) -48.03%
3 years (2019-01-24) 60.71
5 years (2017-01-24) 63.78

Is Neogen Corporation under- or over-valued?

Valuing Neogen Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Neogen Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Neogen Corporation's P/E ratio

Neogen Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 73x. In other words, Neogen Corporation shares trade at around 73x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Neogen Corporation's PEG ratio

Neogen Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9678. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Neogen Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Neogen Corporation's EBITDA

Neogen Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $96.4 million.

The EBITDA is a measure of a Neogen Corporation's overall financial performance and is widely used to measure a its profitability.

Neogen Corporation financials

Revenue TTM $503 million
Operating margin TTM 14.58%
Gross profit TTM $215.1 million
Return on assets TTM 5.06%
Return on equity TTM 6.94%
Profit margin 11.34%
Book value $8.03
Market capitalisation $4.2 billion

TTM: trailing 12 months

Neogen Corporation share dividends

We're not expecting Neogen Corporation to pay a dividend over the next 12 months.

Have Neogen Corporation's shares ever split?

Neogen Corporation's shares were split on a 2:1 basis on 6 June 2021. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Neogen Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Neogen Corporation shares which in turn could have impacted Neogen Corporation's share price.

Neogen Corporation share price volatility

Over the last 12 months, Neogen Corporation's shares have ranged in value from as little as $38.24 up to $48.85. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neogen Corporation's is 0.445. This would suggest that Neogen Corporation's shares are less volatile than average (for this exchange).

Neogen Corporation overview

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site